Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods of selecting internalizing antibodies

a technology of internalizing antibodies and antibodies, applied in the field of immunotherapy, can solve the problems of laborious, time-consuming, and expensive screening of hybridoma-produced antibodies, and achieve the effect of easy derivatization for coupling

Inactive Publication Date: 2009-04-23
RGT UNIV OF CALIFORNIA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes a method for selecting internalizing antibodies or polypeptides that can be internalized into target cells. The method involves contacting target cells with a phage display library, optionally washing the cells to remove non-specifically bound phage, and identifying internalized phage. The internalized phage can then be used to probe the original target cells and isolate the internalizing receptor or receptor epitope. The method can also involve using a subtractive cell line to select for internalizing binding moieties. The invention also provides a multivalent antibody phage display library comprising multiple copies of single-chain antibodies.

Problems solved by technology

Screening of hybridoma-produced antibodies, however, is laborious, time-consuming, and expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of selecting internalizing antibodies
  • Methods of selecting internalizing antibodies
  • Methods of selecting internalizing antibodies

Examples

Experimental program
Comparison scheme
Effect test

example 1

Creation of a Non-Immune Human Fab Phase Antibody Library Containing 109-1011 members

[0174]Manipulation of previous 107 member phage display libraries revealed two major limitations: 1) expression levels of Fabs was too low to produce adequate material for characterization, and 2) the library was relatively unstable. These limitations are a result of creating the library in a phage vector, and the use of the cre-lox recombination system. We therefore decided that the best approach for this project was to create a very large scFv library using a phagemid vector. The goal was to produce a library at least 100 times larger than our previous 3.0×107 member scFv library. The approach taken was to clone the VH and VL library on separate replicons, combine them into an scFv gene repertoire by splicing by overlap extension, and clone the scFv gene repertoire into the phage display vector pHEN1. Human peripheral blood lymphocyte and spleen RNA was primed with IgM heavy chain constant region ...

example 2

Uptake of scFV into Cells by Receptor Mediated Endocytosis and Subsequent Recovery

[0179]The 7.0×109 member scFv phage antibody library described above was selected on the malignant breast tumor cell lines MB231 and ZR-75-1, both with and without negative selections on the normal breast cell line HBL100, Similar results were obtained as described in section above. scFv were isolated that could not distinguish malignant from non-malignant cell lines.

[0180]To increase the specificity of selections, it was hypothesized that phage binding cell surface receptors could be taken up into cells by receptor mediated endocytosis and could then be recovered from cells by lysing the cells. This assumed: 1) that phage could be internalized by receptor mediated endocytosis and 2) that phage could be recovered in the infectious state from within cells prior to lysosomal degradation. The ability to select for internalized phage antibodies would have two major benefits: 1) the identification of antibo...

example 3

Increasing the Affinity of Antibody Fragments with the Desired Binding Characteristics by Creating Mutant Phase Antibody Libraries and Selecting on the Appropriate Breast Tumor Cell Line

[0194]Phage display has the potential to produce antibodies with affinities that cannot be produced using conventional hybridoma technology. Ultra high affinity human antibody fragments could result in excellent tumor penetration, prolonged tumor retention, and rapid clearance from the circulation, leading to high specificity. We therefore undertook a series of experiments to develop methodologies to generate ultra high affinity human antibody fragments. Experiments were performed to answer the following questions: 1) What is the most effective way to select and screen for rare higher affinity phage antibodies amidst a background of lower affinity binders; 2 What is the most effective means to remove bound phage from antigen, to ensure selection of the highest affinity phage antibodies; 3) What is th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

This invention provides methods of selecting antibodies that are internalized into target cells. The methods generally involve contacting target cells with one or more members of an antibody phage display library. The members of the phage display library are also contacted with cells of a subtractive cell line. The target cells are then washed to remove the subtractive cell line cells and members of the phage display library that are non-specifically bound or weakly bound to the target cells. The target cells are cultured under conditions where members of the phage display library can be internalized if bound to an internalizing marker and internalized members of the phage display library are then identified.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. Ser. No. 10 / 855,755 filed May 26, 2004, which application is a divisional of and claims benefit of U.S. Ser. No. 09 / 249,529 filed Feb. 12, 1999, which claims benefit under 35 U.S.C. §119(e) of provisional application U.S. Ser. No. 60 / 082,953, filed on Apr. 24, 1998, which application are herein incorporated by reference in their entirety for all purposes.STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT[0002]This work was supported, in part, by Department of Defense Grants DAMD17-96-1-6244 and DAMD17-94-4433. The government of the United States of America has certain rights in this invention.FIELD OF THE INVENTION[0003]This invention pertains to the fields of immunodiagnostics and immunotherapeutics. The invention provides methods of identifying internalizing antibodies and internalizing receptor ligands, as well as the internalizing receptors bound.BACK...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C40B30/04A61K38/00A61K39/395G01N33/68A61K47/48A61P37/02C07K14/01C07K16/28C07K16/32C12N15/09C12N15/10C12N15/86C12Q1/70C40B20/08C40B40/02C40B50/06G01N33/15G01N33/50G01N33/554G01N33/566
CPCA61K38/00A61K47/48538C07K14/005C07K16/2863C07K16/2881C07K16/32C12N2795/10022C07K2317/622C07K2317/626C07K2317/77C07K2319/02C12N15/1037C12N15/86C07K2317/21A61K47/6843A61P37/02
Inventor MARKS, JAMES D.POUL, MARIE ALIXBECERRIL, BALTAZAR
Owner RGT UNIV OF CALIFORNIA